Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54.5M
-
Number of holders
-
268
-
Total 13F shares, excl. options
-
44.3M
-
Shares change
-
-130K
-
Total reported value, excl. options
-
$2.22B
-
Value change
-
-$14.7M
-
Put/Call ratio
-
0.97
-
Number of buys
-
127
-
Number of sells
-
-118
-
Price
-
$50.07
Significant Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q3 2021
311 filings reported holding EBS - Emergent BioSolutions Inc. - Common Stock as of Q3 2021.
Emergent BioSolutions Inc. - Common Stock (EBS) has 268 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.3M shares
of 54.5M outstanding shares and own 81.36% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.83M shares), VANGUARD GROUP INC (4.92M shares), Neuberger Berman Group LLC (3.31M shares), JANUS HENDERSON GROUP PLC (2.87M shares), STATE STREET CORP (2.4M shares), EARNEST PARTNERS LLC (2.24M shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (1.4M shares), DIMENSIONAL FUND ADVISORS LP (987K shares), NORTHERN TRUST CORP (921K shares), and SNYDER CAPITAL MANAGEMENT L P (844K shares).
This table shows the top 268 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.